mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.02 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.02 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.02 |
mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.02 |
mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.02 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.02 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
-0.073 |
0.02 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |